Clinical Trial Update: Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether targeting a lower blood pressure with reduced norepinephrine improves outcomes and cost-effectiveness in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Myocardial Infarction

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Cardiogenic Shock, Myocardial Infarction | Phase 4 | Status: RECRUITING